SwissMedic-2021-0089-V089

Type II variation for application SwissMedic-2021-0089. Type II variation: Container Closure Change for Atezolimumab-R — minor update

Variation Number
SwissMedic-2021-0089-V089
Type
Type II
Application
SwissMedic-2021-0089
Change
CHG-2024-0089
Status
Blocked
Fee
€21,879
Submitted
2023-04-16
Approved
—
Description

Type II variation: Container Closure Change for Atezolimumab-R — minor update